The Board of Directors of Icure Pharmaceutical Incorporation has authorized a buyback plan on February 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,922 KRW | -0.21% | -1.03% | -8.04% |
1st Jan change | Capi. | |
---|---|---|
-8.04% | 52.3M | |
+10.09% | 19.15B | |
0.00% | 17.54B | |
-1.32% | 10.84B | |
-8.05% | 10.22B | |
+0.76% | 6.53B | |
+10.78% | 6B | |
-2.19% | 4.41B | |
-18.05% | 3.78B | |
-3.77% | 3.58B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Icure Pharmaceutical Incorporation authorizes a Buyback Plan.